12:00 AM
Aug 27, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Gattex regulatory update

FDA's Gastrointestinal Drugs Advisory Committee will meet on Oct. 16 to discuss an NDA from NPS for Gattex teduglutide to treat short bowel syndrome (SBS). The PDUFA date is Dec....

Read the full 126 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >